SCHEDULE-DEPENDENT ENHANCEMENT OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE INCORPORATION INTO HL-60 DNA BY DEOXYGUANOSINE
- 1 January 1984
- journal article
- research article
- Vol. 44 (4) , 1530-1535
Abstract
The ability was studied of the purine deoxynucleoside deoxy-guanosine (dGuo) to enhance 1.beta.-D-arabinofuranosylcytosine (ara-C) [an antitumor agent] incorporation into DNA of HL-60 cultured human leukemia cells. The effects of dGuo on ara-C incorporation into DNA were compared to those of thymidine (dThd), a pyrimidine deoxynucleoside known to augment ara-C effects both in vitro and in vivo. Both deoxynucleosides doubled the cells in the S phase of the cell cycle within the exposure periods (up to 48 h) and concentrations (10-1000 .mu.M) tested. Both deoxynucleosides enhanced ara-C incorporation into DNA equally. dThd and dGuo differed in the schedule required to achieve this effect. Simultaneous exposure to cells to ara-C and dThd increased ara-C incorporation into DNA .apprx. 3.5-fold. Preincubation of cells with dThd for 16 h prior to the addition of ara-C further enhanced ara-C incorporation into DNA (to .apprx. 5-fold) in direct proportion to the dThd-induced increase in cells in S phase. Preincubation was essential for dGuo, since 16-h preincubation of cells with concentrations as low as 30 .mu.M caused augmentation of ara-C incorporation into DNA; but simultaneous exposure of cells to dGuo and ara-C caused no augmentation of ara-C incorporation into DNA. The augmentation of ara-C incorporation into DNA caused by preincubation of the cells with dGuo results from a number of factors, including the cytokinetic effect of increasing the percentage of cells in S phase and the reduction of intracellular dCTP pools. Maximal dGuo enhancement of ara-C incorporation into DNA (.apprx. 5-fold) required > 100 .mu.M dGuo, 16-h preincubation with dGuo, and final incubation of cells with ara-C after removal of dGuo. This further augmentation of ara-C incorporation into DNA caused by the removal of dGuo prior to adding ara-C was explained by the observed inhibition of ara-C phosphorylation by dGuo concentrations > 100 .mu.M.This publication has 15 references indexed in Scilit:
- Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA.Proceedings of the National Academy of Sciences, 1981
- Potentiation of 1-β-d-arabinofuranosylcytosine in hepatoma cells by 2′-deoxyadenosine or 2′-deoxyguanosineBiochemical Pharmacology, 1981
- BIOCHEMICAL AND ANTI-TUMOR EFFECTS OF THE COMBINATION OF THYMIDINE AND 1-BETA-D-ARABINOFURANOSYLCYTOSINE AGAINST LEUKEMIA-L12101981
- CYTO-TOXIC AND CYTOKINETIC EFFECTS OF THYMIDINE, 5-FLUOROURACIL, AND DEOXYCYTIDINE ON HELA-CELLS IN CULTURE1981
- Correlation of cytotoxicity with incorporation of ara-C into DNA.Journal of Biological Chemistry, 1980
- EFFECTS OF THYMIDINE AND THYMIDINE PLUS 5-FLUOROURACIL ON THE GROWTH-KINETICS OF A HUMAN LYMPHOID-CELL LINE1980
- ENHANCEMENT OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE ACCUMULATION WITHIN L1210 CELLS AND INCREASED CYTO-TOXICITY FOLLOWING THYMIDINE EXPOSURE1980
- Deoxyguanosine Triphosphate as a Possible Toxic Metabolite in the Immunodeficiency Associated with Purine Nucleoside Phosphorylase DeficiencyJournal of Clinical Investigation, 1978
- Abnormal Purine Metabolism and Purine Overproduction in a Patient Deficient in Purine Nucleoside PhosphorylaseNew England Journal of Medicine, 1976
- PLAQUE FORMATION AND ISOLATION OF PURE LINES WITH POLIOMYELITIS VIRUSESThe Journal of Experimental Medicine, 1954